Enzolytics, Inc. (OTCMKTS:ENZC) Sees Large Increase in Short Interest

Enzolytics, Inc. (OTCMKTS:ENZC) was the recipient of a large increase in short interest in February. As of February 15th, there was short interest totalling 662,300 shares, an increase of 331,050.0% from the January 31st total of 200 shares. Based on an average trading volume of 15,741,500 shares, the days-to-cover ratio is currently 0.0 days.

Enzolytics Price Performance

OTCMKTS:ENZC traded down $0.00 during midday trading on Thursday, reaching $0.00. 1,259,958 shares of the stock traded hands, compared to its average volume of 6,350,999. Enzolytics has a 12-month low of $0.00 and a 12-month high of $0.02.

About Enzolytics

Enzolytics Inc, a drug development company, focuses to the commercialization of its proprietary proteins for the treatment of debilitating infectious diseases. Its patented anti-HIV therapeutics and a proprietary methodology for producing human IgG1 monoclonal antibodies for treating infectious diseases with non-toxic passive immunotherapy.